These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 26581138

  • 1. Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.
    Kelsey CR, Das S, Gu L, Dunphy FR, Ready NE, Marks LB.
    Int J Radiat Oncol Biol Phys; 2015 Dec 01; 93(5):997-1004. PubMed ID: 26581138
    [Abstract] [Full Text] [Related]

  • 2. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC, Herndon JE, Rosenman J, Carey RW, Chung CT, Bernard S, Leone L, Seagren S, Green M.
    J Clin Oncol; 1998 Nov 01; 16(11):3528-36. PubMed ID: 9817271
    [Abstract] [Full Text] [Related]

  • 3. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer C, Cohen RB, Simone CB.
    Cancer; 2017 Nov 01; 123(21):4244-4251. PubMed ID: 28678434
    [Abstract] [Full Text] [Related]

  • 4. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
    Marks LB, Garst J, Socinski MA, Sibley G, Blackstock AW, Herndon JE, Zhou S, Shafman T, Tisch A, Clough R, Yu X, Turrisi A, Anscher M, Crawford J, Rosenman J, Carolina Conformal Therapy Consortium.
    J Clin Oncol; 2004 Nov 01; 22(21):4329-40. PubMed ID: 15514374
    [Abstract] [Full Text] [Related]

  • 5. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G, Comella P, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Parziale A, Comella G.
    J Clin Oncol; 1997 Apr 01; 15(4):1409-17. PubMed ID: 9193333
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
    Takeda K, Nemoto K, Saito H, Ogawa Y, Takai Y, Yamada S.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):626-9. PubMed ID: 15936536
    [Abstract] [Full Text] [Related]

  • 8. Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.
    Comella G, Frasci G, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Ruffolo P, Comella P.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-113-S12-116. PubMed ID: 9331134
    [Abstract] [Full Text] [Related]

  • 9. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers SB, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J.
    Lung Cancer; 2011 Feb 01; 71(2):166-72. PubMed ID: 20541833
    [Abstract] [Full Text] [Related]

  • 10. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
    Rodríguez N, Algara M, Foro P, Lacruz M, Reig A, Membrive I, Lozano J, López JL, Quera J, Fernández-Velilla E, Sanz X.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):810-7. PubMed ID: 18755556
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I study of pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer.
    Li BS, Gong HY, Huang W, Yi Y, Yu JM, Wang ZT, Zhang ZC, Sun HF, Li HS, Wang LY.
    Am J Clin Oncol; 2012 Apr 01; 35(2):115-9. PubMed ID: 21555933
    [Abstract] [Full Text] [Related]

  • 13. Dose-escalated Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer.
    Kim JO, Chu KP, Fairchild A, Ghosh S, Butts C, Chu Q, Gabos Z, Joy AA, Nijjar T, Robinson DM, Sangha R, Scrimger R, Smylie M, Yee D, Roa WH.
    Am J Clin Oncol; 2017 Jun 01; 40(3):294-299. PubMed ID: 25333733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.
    Komaki R, Swann RS, Ettinger DS, Glisson BS, Sandler AB, Movsas B, Suh J, Byhardt RW.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):342-50. PubMed ID: 15890573
    [Abstract] [Full Text] [Related]

  • 16. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
    Iwasaki Y, Ohsugi S, Natsuhara A, Tsubokura T, Harada H, Ueda M, Arimoto T, Hara H, Yamada T, Takesako T, Kohno K, Hosogi S, Nakanishi M, Marunaka Y, Nishimura T.
    Cancer Chemother Pharmacol; 2006 Dec 01; 58(6):735-41. PubMed ID: 16565832
    [Abstract] [Full Text] [Related]

  • 17. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
    Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1106-11. PubMed ID: 16730134
    [Abstract] [Full Text] [Related]

  • 18. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy 
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
    You J, Yu H, Song M, Shi C, Wang X, Zheng Y, Yu R, Shi A, Zhu G.
    Zhongguo Fei Ai Za Zhi; 2017 Jan 20; 20(1):28-34. PubMed ID: 28103970
    [Abstract] [Full Text] [Related]

  • 19. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K, Sunaga N, Yanagitani N, Kawata T, Utsugi M, Shimizu K, Ebara T, Kawamura H, Nonaka T, Ishikawa H, Sakurai H, Suga T, Hara K, Hisada T, Ishizuka T, Nakano T, Mori M.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):109-14. PubMed ID: 18929446
    [Abstract] [Full Text] [Related]

  • 20. Phase 2 study of accelerated hypofractionated thoracic radiation therapy and concurrent chemotherapy in patients with limited-stage small-cell lung cancer.
    Xia B, Hong LZ, Cai XW, Zhu ZF, Liu Q, Zhao KL, Fan M, Mao JF, Yang HJ, Wu KL, Fu XL.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):517-23. PubMed ID: 25481679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.